Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.64
-6.3%
$23.52
$9.56
$25.67
$1.79B1.272.14 million shs2.55 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$240.93
+0.1%
$246.70
$166.64
$310.00
$9.38B0.4535,241 shs280,040 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$1.89
+18.9%
$1.77
$0.78
$2.38
$238.13M1.2796,964 shs7.71 million shs
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.00%-6.48%-7.74%+31.86%+107.14%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-0.65%-1.15%-18.95%+47.22%
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%+23.53%-7.35%+3.31%+51.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
National Vision Holdings, Inc. stock logo
EYE
National Vision
3.0054 of 5 stars
2.32.00.03.33.90.80.0
Penumbra, Inc. stock logo
PEN
Penumbra
4.6365 of 5 stars
3.54.00.03.72.72.51.9
The Beauty Health Company stock logo
SKIN
Beauty Health
1.7531 of 5 stars
3.00.00.00.03.33.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.60
Moderate Buy$24.739.22% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.94
Moderate Buy$300.4724.71% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
2.00
Hold$2.6338.89% Upside

Current Analyst Ratings Breakdown

Latest SKIN, EYE, WGB, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$17.00 ➝ $22.00
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$24.00 ➝ $27.00
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$30.00 ➝ $28.00
8/1/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$3.00 ➝ $4.00
7/31/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $266.00
7/30/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$300.00 ➝ $310.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$330.00 ➝ $325.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$330.00 ➝ $335.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$315.00 ➝ $290.00
7/30/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$283.00 ➝ $285.00
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.89B0.95$1.64 per share13.84$10.76 per share2.10
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B7.87$2.89 per share83.31$33.18 per share7.26
The Beauty Health Company stock logo
SKIN
Beauty Health
$334.30M0.71$0.06 per share29.89$0.41 per share4.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$28.50M-$0.18N/A83.852.73-0.75%3.56%1.49%N/A
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7664.0848.092.1611.54%11.55%8.76%10/29/2025 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.41N/AN/AN/A-6.13%-36.17%-2.77%N/A

Latest SKIN, EYE, WGB, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.06$0.03+$0.09$0.03$74.67 million$78.20 million
8/6/2025Q2 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.12$0.18+$0.06$0.11$469.21 million$486.42 million
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.52
0.35
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04
The Beauty Health Company stock logo
SKIN
Beauty Health
12.01
7.47
6.43

Institutional Ownership

CompanyInstitutional Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,41179.05 million76.92 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.36 millionOptionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030125.99 million74.34 millionOptionable

Recent News About These Companies

Use AI for skin care info, not treatment decisions: Expert
Confused about skincare? Start with this beginner’s guide for healthier skin
Beauty Health (NASDAQ:SKIN) Rating Increased to Buy at Wall Street Zen
Beauty Health (SKIN) Q2 Net Jumps 62%
Baobab fruit powder: Your secret to glowing skin
Here’s how to create radiant skin from the inside out

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
National Vision stock logo

National Vision NASDAQ:EYE

$22.64 -1.53 (-6.33%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$22.84 +0.20 (+0.86%)
As of 08/8/2025 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Penumbra stock logo

Penumbra NYSE:PEN

$240.93 +0.19 (+0.08%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$240.17 -0.76 (-0.32%)
As of 08/8/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$1.89 +0.30 (+18.87%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.04 +0.16 (+8.20%)
As of 08/8/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.